A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer

• R Collins,
• E Fenwick,
• R Trowman,
• R Perard,
• G Norman,
• K Light,
• A Birtle,
• S Palmer,
• R Riemsma

Affiliations

R Collins

E Fenwick

R Trowman

R Perard

G Norman

K Light

A Birtle

S Palmer

R Riemsma

Centre for Reviews and Dissemination, University of York, UK